{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:03:27Z","timestamp":1791482607439,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.psyneuen.2013.03.020","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T14:41:40Z","timestamp":1366728100000},"page":"2010-2022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Nrf2 participates in depressive disorders through an anti-inflammatory mechanism"],"prefix":"10.1016","volume":"38","author":[{"given":"Mar\u00eda Dolores","family":"Mart\u00edn-de-Saavedra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Budni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio P.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"G\u00f3mez-Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lorrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"del Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Lastres-Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda","family":"Tordera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00f9cia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela G.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2013.03.020_bib0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1165\/rcmb.2006-0340TR","article-title":"How many transcription factors does it take to turn on the heme oxygenase-1 gene?","volume":"36","author":"Alam","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.mcg.0000210099.36500.fe","article-title":"2nd Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches","volume":"40","author":"Asnis","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2004.06.009","article-title":"BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration","volume":"155","author":"Barrientos","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0020","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.npp.1301606","article-title":"Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis","volume":"33","author":"Ben Menachem-Zidon","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0025","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0030","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/sj.npp.1300982","article-title":"Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment","volume":"31","author":"Czeh","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0035","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2174\/1381612043452901","article-title":"Induction of cytoprotective genes through Nrf2\/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases","volume":"10","author":"Chen","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200502000-00026","article-title":"Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans","volume":"102","author":"Dembo","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0045","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archpsyc.60.8.804","article-title":"Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects","volume":"60","author":"Dwivedi","year":"2003","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0050","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","article-title":"Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression","volume":"62","author":"Felger","year":"2007","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneumeth.2010.04.026","article-title":"Semi-automated Sholl analysis for quantifying changes in growth and differentiation of neurons and glia","volume":"190","author":"Gensel","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0269881106063264","article-title":"Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine\/malonate combination: implications for serotonin\/dopamine interactions","volume":"20","author":"Goni-Allo","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.mp.4002055","article-title":"Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression","volume":"13","author":"Goshen","year":"2008","journal-title":"Mol. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0070","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/107999001317205231","article-title":"IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment","volume":"21","author":"Guillemin","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.pain.2008.01.021","article-title":"Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat","volume":"138","author":"Gwak","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0080","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0090","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/nm1669","article-title":"Antidepressant actions of the exercise-regulated gene VGF","volume":"13","author":"Hunsberger","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0095","doi-asserted-by":"crossref","first-page":"e11838","DOI":"10.1371\/journal.pone.0011838","article-title":"Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1","volume":"5","author":"Innamorato","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0100","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"Innamorato","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1358\/mf.2001.23.8.662131","article-title":"Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors","volume":"23","author":"Jain","year":"2001","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0120","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1089\/ars.2010.3731","article-title":"Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism","volume":"14","author":"Jazwa","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0125","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.pnpbp.2006.12.018","article-title":"The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test","volume":"31","author":"Kaster","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","article-title":"Depressive-like behavior induced by tumor necrosis factor-alpha in mice","volume":"62","author":"Kaster","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.0708092105","article-title":"IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress","volume":"105","author":"Koo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0145","first-page":"139","article-title":"An important role of Nrf2-ARE pathway in the cellular defense mechanism","volume":"37","author":"Lee","year":"2004","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0150","first-page":"287","article-title":"The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression","volume":"29","author":"Maes","year":"2008","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0155","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0278-5846(92)90056-K","article-title":"Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness","volume":"16","author":"Maes","year":"1992","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0278-5846(93)90045-T","article-title":"Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness","volume":"17","author":"Maes","year":"1993","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1092852900016734","article-title":"Inflammation, glutamate, and glia in depression: a literature review","volume":"13","author":"McNally","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","article-title":"Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis","volume":"11","author":"Mikova","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0180","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2011.05.005","article-title":"Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action","volume":"46","author":"Nowacka","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0190","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2010","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0195","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease","volume":"58","author":"Rojo","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mcn.2008.06.007","article-title":"Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death","volume":"39","author":"Rojo","year":"2008","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0205","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/IAI.70.7.3959-3961.2002","article-title":"Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection","volume":"70","author":"Sakash","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0210","first-page":"524","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"7","author":"Schildkraut","year":"1965","journal-title":"J. Neuropsychiat. Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0215","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ptr.1520","article-title":"Reversal of LPS-induced immobility in mice by green tea polyphenols: possible COX-2 mechanism","volume":"18","author":"Singal","year":"2004","journal-title":"Phytother. Res."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(96)00169-4","article-title":"Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)","volume":"56","author":"Siuciak","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0225","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/depr.3050030403","article-title":"Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression","volume":"3","author":"Sluzewska","year":"1995","journal-title":"Depression"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0240","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI25790","article-title":"Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis","volume":"116","author":"Thimmulappa","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0245","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1073\/pnas.0610282104","article-title":"VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants","volume":"104","author":"Warner-Schmidt","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0250","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2007.10.013","article-title":"VEGF as a potential target for therapeutic intervention in depression","volume":"8","author":"Warner-Schmidt","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0255","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1749-6632.2000.tb05412.x","article-title":"Illness, cytokines, and depression","volume":"917","author":"Yirmiya","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0260","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1523\/JNEUROSCI.1683-07.2007","article-title":"Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury","volume":"27","author":"Zhao","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2013.03.020_bib0265","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/STROKEAHA.107.486506","article-title":"Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage","volume":"38","author":"Zhao","year":"2007","journal-title":"Stroke"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:42:48Z","timestamp":1759682568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453013001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0306453013001157"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.03.020","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 participates in depressive disorders through an anti-inflammatory mechanism","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}